| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3863891 | The Journal of Urology | 2014 | 6 Pages |
Abstract
A total of 36 patients with pure seminoma were found to have viable pure seminoma at post-chemotherapy retroperitoneal lymph node dissection. While 5-year cancer specific survival was 54%, these surgeries are technically demanding and only a minority of patients achieves a durable cure from surgery alone.
Keywords
STMCSSHDCTDODCSMGerminomaNEDRPLNDHCGLymph node excisionCancer specific survivalPositron emission tomographyRetroperitoneal lymph node dissectionSeminomaHigh dose chemotherapydead of diseaseCancer specific mortalitySerum tumor markersHCG, Human chorionic gonadotropinno evidence of diseasecomplete responsePET
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kevin R. Rice, Stephen D.W. Beck, Richard Bihrle, K. Clint Cary, Lawrence H. Einhorn, Richard S. Foster,